Please delete this page upon discussion or finalisation of document]January 3rd, 2024
FiledJanuary 3rd, 2024The clauses in this Master Clinical Trial Agreement (MCTA) have been reviewed and agreed by legal representatives from Singapore Association of Pharmaceutical Industries (SAPI), Singapore Health Services (SingHealth), National Healthcare Group (NHG) and National University Health System (NUHS) with the aim to expedite agreement review process between Sponsor and Singapore’s Public Healthcare Institutions.
The clauses in this Master Clinical Trials Agreement (MCTA) has been reviewed and agreed by legal representatives from Singapore Association of Pharmaceutical Industries (SAPI), Singapore Health Services (SingHealth), National Healthcare Group (NHG)...October 14th, 2022
FiledOctober 14th, 2022To insert Sponsor Logo if required Upon completion Remove instruction Remove Table Border To insert Institution Logo if required Upon completion Remove instruction Remove Table Border
Please delete this page upon discussion or finalisation of document]October 14th, 2022
FiledOctober 14th, 2022The clauses in this Master Clinical Trial Agreement (MCTA) have been reviewed and agreed by legal representatives from Singapore Association of Pharmaceutical Industries (SAPI), Singapore Health Services (SingHealth), National Healthcare Group (NHG) and National University Health System (NUHS) with the aim to expedite agreement review process between Sponsor and Singapore’s Public Healthcare Institutions.